The US FDA has granted AstraZeneca's (AZ) Brilinta a priority review for patients with a history of heart attack. The announcement is good news for AZ, which has identified Brilinta (ticagrelor ...

AstraZeneca has lifted the veil on the large-scale THALES trial of its antiplatelet drug Brilinta in stroke, the company’s last big hope for recouping its substantial investment in the medicine.

Simon Thompson: A sports equipment company has traded through challenging times, but could soon return to prof ...

The Oxford-AstraZeneca Covid vaccine is being withdrawn worldwide, the company has said, months after the pharmaceutical firm ...

According to US secondary stroke prevention guidelines, patients with ESUS should not be treated with anticoagulants or ...

"It's appalling the way AstraZeneca has been treated. I wouldn't blame them if they were thoroughly fed up and decided to bow out of the Covid vaccine business." That was the view from one of the ...

At a thrombosis research center, an observational study is underway investigating the impact of numerous biomarkers on ...

LONDON, Sept 9 (Reuters) - Detailed results from one of AstraZeneca's (AZN.L), opens new tab key lung cancer trials released on Monday showed that its experimental precision drug did not ...

AstraZeneca has started to move away from providing its Covid-19 vaccine to countries on a not-for-profit basis. The drugs giant has signed a series of for-profit agreements for next year, and ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

This is the online edition of ESMO in 30 Seconds, a pop-up newsletter from the European Society for Medical Oncology’s annual meeting in Barcelona, Spain. Sign up for the remaining editions here.

Cobblestone Capital Advisors LLC NY raised its holdings in shares of AstraZeneca PLC (NASDAQ:AZN – Free Report) by 4.6% during the second quarter, according to the company in its most recent ...